Salarius Pharmaceuticals Inc. (SLRX)

Name: Salarius Pharmaceuticals Inc. (SLRX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Salarius Pharmaceuticals Inc. (SLRX)

Stock Card

$0.62

$-0.20 (-24.37%)

As on 05-Feb-2026 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

1.1

Div. Yield

0 %

Salarius Pharmaceuticals (SLRX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.62 High: 0.73

52 Week Range

Low: 0.51 High: 34.65

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

1.5
Debt to Equity

0
Book Value

$--
EPS

$-46.6
Face value

--
Shares outstanding

5,862,178

9 Years Aggregate

CFO

$-166.65 Mln

EBITDA

$-182.18 Mln

Net Profit

$-194.32 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Salarius Pharmaceuticals (SLRX)	-4.4	-4.9	-80.6	-98.1	-87.2	-83.3	-74.8
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 05-Feb-2026 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Salarius Pharmaceuticals (SLRX)	-97.6	-64.3	-57.5	-87.7	-45.5	-75.9	-54.2
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Salarius Pharmaceuticals (SLRX)	0.6	4.9	0.0	-5.0	-114,018.1	-232.2	--	1.1
Applied Therapeutics (APLT)	0.1	14.9	1.0	-18.1	-10,073.6	--	--	7.7
FibroGen (FGEN)	7.5	39.3	-118.1	215.7	109.1	--	--	53.8

Shareholding Pattern

View Details

About Salarius Pharmaceuticals (SLRX)

Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and... manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas. Read more

CEO, President & Director

Mr. David J. Arthur M.B.A.
CEO, President & Director

Mr. David J. Arthur M.B.A.
Headquarters

Houston, TX
Website

https://www.salariuspharma.com

FAQs for Salarius Pharmaceuticals (SLRX)

What is the current share price of Salarius Pharmaceuticals Inc (SLRX) Today?

The share price of Salarius Pharmaceuticals Inc (SLRX) is $0.62 (NASDAQ) as of 05-Feb-2026 09:30 EDT. Salarius Pharmaceuticals Inc (SLRX) has given a return of -87.23% in the last 3 years.

What is the current PB & PE ratio of Salarius Pharmaceuticals Inc (SLRX)?

Since, TTM earnings of Salarius Pharmaceuticals Inc (SLRX) is negative, P/E ratio is not available.
The P/B ratio of Salarius Pharmaceuticals Inc (SLRX) is 1.13 times as on 05-Feb-2026, a 79 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-0.02	0.08
2023	0.00	0.00
2022	0.00	0.00
2021	0.00	0.00
2020	0.00	0.00

What is the 52 Week High and Low of Salarius Pharmaceuticals Inc (SLRX)?

The 52-week high and low of Salarius Pharmaceuticals Inc (SLRX) are Rs 34.65 and Rs 0.51 as of 29-Aug-2026.

What is the market cap of Salarius Pharmaceuticals Inc (SLRX)?

Salarius Pharmaceuticals Inc (SLRX) has a market capitalisation of $ 5 Mln as on 05-Feb-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Salarius Pharmaceuticals Inc (SLRX)?

Before investing in Salarius Pharmaceuticals Inc (SLRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.